Recently, the bioinformatics analysis of gene expression data from the Broad–Novartis Cancer Cell Line Encyclopedia (CCLE) and TCGA identified GBM as one of the tumors where NRF2 is more often up-regulated (Pölönen et al, 2019). This evidence concerns the gene NFE2L2 and glioblastoma.